Revenue Breakdown
Composition ()
No data
Revenue Streams
Tandem Diabetes Care Inc (TNDM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Pump, accounting for 44.2% of total sales, equivalent to $110.11M. Other significant revenue streams include Supplies and other - Domestic and Supplies and other-International. Understanding this composition is critical for investors evaluating how TNDM navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Tandem Diabetes Care Inc maintains a gross margin of 53.88%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -8.05%, while the net margin is -8.49%. These profitability ratios, combined with a Return on Equity (ROE) of -109.73%, provide a clear picture of how effectively TNDM converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TNDM competes directly with industry leaders such as ENOV and CNMD. With a market capitalization of $1.32B, it holds a leading position in the sector. When comparing efficiency, TNDM's gross margin of 53.88% stands against ENOV's 52.23% and CNMD's 56.59%. Such benchmarking helps identify whether Tandem Diabetes Care Inc is trading at a premium or discount relative to its financial performance.
